期刊文献+

降钙素原在长期接受免疫抑制治疗的重症患者感染诊断中的作用 被引量:19

The value of procalcitonin for diagnosing infection in critically ill patients receiving long-termimmunosuppressive therapy
原文传递
导出
摘要 目的探索降钙素原(PCT)在长期接受免疫抑制治疗的重症患者感染诊断中的价值。方法前瞻性研究,连续纳入2008年1月至2009年12月北京协和医院ICU中伴有长期应用糖皮质激素或免疫抑制剂的基础疾病患者,怀疑感染时测定血PCT。结果入选103例,年龄(47.9±21.9)岁,其中女性65例。感染组84例,非感染组19例。感染组PCT高于非感染组[2.58(0.08-44.65)pg/L比0.62(0.15-6.00)pg/L,P=0.002];不同病原菌感染的患者,其PCT水平依次为细菌3.41(0.45-44.65)pg/L、真菌0.99(0.28-6.67)pg/L、病毒0.11(0.08-0.20)pg,/L(P=0.018);PCT诊断细菌感染的AUCRoc为0.867(P=0.000)。PCT水平与年龄、肾功能、感染部位及预后无关(P〉0.05),而与细菌感染(OR=5.1,P=0.031)及感染性休克(OR:7.5,P=0.027)独立相关。结论免疫抑制治疗不影响PCT释放,PCT水平检测在该人群感染,特别是细菌感染诊断中发挥重要作用。 Objective To assess the value of procalcitonin (PCT) measurement to difierentiate infection from non-infection in critically ill patients requiring long-term immunosuppressive therapy. Methods A prospective study was conducted in patients with underlying diseases requiring corticosteroids or chemotherapy in ICU from January 2008 to December 2009. Patients were divided into the infection group and the non-infection group and their PCT levels were compared. Results A total of 103 patients (65 women) were enrolled in this prospective study [ aged (47.9 ± 21.9) years old] with 84 in the infection group and 19 in the non-infection group. The baseline level of PCT was significantly higher in infection than in non-infection patients [ 2. 58 (0. 08-44. 65 ) pg/L vs 0. 62 (0. 15-6. 00 ) pg/L, P = 0. 002 ]. Different levels of PCT were manifested in different pathogen groups with 3.41 ( 0. 45-44. 65 ) pg/L in bacteria infection, 0. 99(0. 28-6. 67) pg/L in fungus infection, 0. 11 (0. 08-0. 20) pg/L in virus infection group (P = 0.018). The AUCRoc of PCT was 0. 867 for diagnostic bacterial infection. By multivariate analysis, the factors associated with the level of PCT were bacteria infection ( OR 5.1, P = 0. 031 ) and septic shock ( OR 7.5, P = 0. 027), while the factors not associated with the level of PCT were age, renal function, infection site and prognosis ( P 〉 0. 05 ). Conclusions The level of PCT is increased in the critically ill patients requiring immunosuppressive therapy with infection and it can be used for diagnosis for bacterial infection.
出处 《中华内科杂志》 CAS CSCD 北大核心 2012年第3期192-196,共5页 Chinese Journal of Internal Medicine
关键词 感染 降钙素原 重症患者 免疫抑制治疗 Infection Procalcitonin Critically ill patients Immunosuppressive therapy
  • 相关文献

二级参考文献43

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:424
  • 2任成山.对多器官功能衰竭概念和诊断标准的新认识[J].中国危重病急救医学,1995,7(6):344-345. 被引量:37
  • 3Müller B,Becker KL.Procalcitonin:how a hormone became a marker and mediator of sepsis.Swiss Med Wkly,2001,131:595-602.
  • 4Becker KL,Nylén ES,White JC,et al.Clinical review 167:Procalcitonin and the calcitonin gene family of peptides in inflammation,infection,and sepsis:a journey from calcitonin back to its precursors.J Clin Endocrinol Metab,2004,89:1512-1525.
  • 5Castelli GP,Pognani C,Meisner M,et al.Procalcitonin and Creactive protein during systemic inflammatory response syndrome,sepsis and organ dysfunction.Crit Care,2004,8:R234-242.
  • 6Endo S,Aikawa N,Fujishima S,et al.Usefulness of procalcitonin serum level for the discrimination of severe sepsis from sepsis:a multicenter prospective study.J Infect Chemother,2008,14:244-249.
  • 7Harbarth S,Holeckova K,Froidevaux C,et al.Diagnostic value of procalcitonin,interleukin-6,and interleukin-8 in critically ill patients admitted with suspected sepsis.Am J Respir Crit Care Med,2001,164:396-402.
  • 8Simon L,Gauvin F,Amre DK,et al.Serum procalcitonin and Creactive protein levels as markers of bacterial infection:a systematic review and meta-analysis.Clin Infect Dis,2004,39:206-217.
  • 9Uzzan B,Cohen R,Nicolas P,et al.Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma:a systematic review and meta-analysis.Crit Care Med,2006,34:1996-2003.
  • 10Oberhoffer M,Stonans I,Russwurm S,et al.Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsisrelated cytokines in vitro.J Lab Clin Med,1999,134:49-55.

共引文献1616

同被引文献178

引证文献19

二级引证文献143

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部